Advancing the discovery of CNS active drugs: an interview with Li Yu and Holger Fischer
At AAPS 2019 PharmSci 360 (3–6 November 2019; TX, USA), we spoke with Li Yu and Holger Fischer (both at Roche; NY, USA and Basel, Switzerland, respectively) to learn more about their work on entrectinib, a novel drug with the ability to cross the blood–brain barrier and treat brain tumors.
Please sign in or register for FREE
Sign in to RxNet
Not yet a member? Become a member FREE to:
- Get unlimited access to ALL CONTENT
- Read selected articles from journals such as Future Medicinal Chemistry FREE
- Receive a weekly email roundup of the latest news and expert opinions
Did you know?
Your RxNet account also gives you access to communities on regenerative medicine, real-world evidence and 3D printing in medicine. Find out more>>